0.25% chlorhexidine gluconate gel. A protective topical microbicide

Area of Science:

• Reproductive Health
• Microbiology
• Infectious Diseases

Background:

• Chlamydial infections represent a significant global health concern, with millions of new cases annually.
• The vaginal ecosystem plays a crucial role in maintaining reproductive health and preventing infections.

Purpose of the Study:

• To evaluate the efficacy of a 0.25% chlorhexidine gluconate vaginal gel in preventing chlamydial infections.
• To assess the impact of the chlorhexidine gluconate gel on the vaginal flora and cervicovaginal tissues.

Main Methods:

• The study involved twelve non-human primates treated with a single application of 0.25% chlorhexidine gluconate gel.
• Microbiologic analysis and colposcopy were used to assess vaginal flora and tissue changes before and after treatment.
• A subset of animals received a cervical inoculation of Chlamydia trachomatis post-gel application to test protective efficacy.

Main Results:

• Vaginal flora, including lactobacilli, remained largely unaffected by the chlorhexidine gluconate gel.
• All control animals inoculated with Chlamydia trachomatis became infected.
• None of the animals pretreated with the chlorhexidine gluconate gel showed signs of Chlamydia trachomatis infection.

Conclusions:

• A single application of 0.25% chlorhexidine gluconate vaginal gel demonstrated significant protective effects against chlamydial infection.
• The gel did not adversely impact the vaginal ecosystem or cause significant changes in cervicovaginal tissues.
• Chlorhexidine gluconate gel presents a potential strategy for preventing chlamydial infections.